期刊文献+

急性心肌梗死后心率变异性和心源性猝死危险性的关系 被引量:5

The relationship between heart rate variability and the risk of sudden cardiac death after acute myocardial infarction
下载PDF
导出
摘要 目的:探讨急性心肌梗死(AMI)的心率变异性(HRV)与心源猝死(SCD)风险的相关性.方法:选择2010-06/2014-06间我院接收的35例AMI后SCD患者和同期体检健康者35例作回顾性研究,对比观察两组人群的临床HRV相关指标数据的差异.探讨临床AMI后的SCD患者的HRV各指标特征,为临床预后提供参考依据.结果:同健康者相比,发生AMI后猝死患者的全窦性心搏RR间期标差(SDNN)、RR间期平均标差(SDANN)、RR间期邻差方根(RMSSD)、50瑚以上NN期邻差百分比(PNN50)与低高频比值(LF/HF)等HRV指标数据值均显著更低(P<0.05).结论:AMI后发生SCD者的HRV各项指标数据与健康者间存在明显差别,在临床诊断中可根据受检者的HRV数据特征对其发生SCD的风险进行预测,可起到降低临床中SCD发生率及加强AMI预后的作用. AIM: To study the correlation of of heart rate variability (HRV) and risk of sudden cardiac death (SCD) after acute myocardial infarction (AMI). METHODS: Select 35 cases of patients with SCD after AMI received in our hospital and other 35 healthy persons as research object retrospectively from June 2010 to June 2014, differences of related indexes of clinical HRV were observed and compared between the two groups. Explore HRV parameters in patients with SCD after AMI, and provide the reference to clinical prognosis. RESULTS: Compared with healthy people, the HRV indexes SDNN, SDANN, RMSSD, PNN50 and LF/HF in patients with sudden death after AMI were significantly lower (P 〈 0.05). CONCLUSION: There are obvious differences in HRV indexes between patients with SCD after AM and healthy people. And the occurrence risk of SCD can be predicted based on the characteristics of HRV data in clinical diagnosis, which can reduce the occurrence rate of SCD in the clinical prognosis and strengthen prognosis after AMI.
作者 张建丽
出处 《转化医学电子杂志》 2015年第4期51-52,共2页 E-Journal of Translational Medicine
关键词 AMI HRVF SCD风险 相关性 AMI HRVF SCD risk correlation
  • 相关文献

参考文献2

二级参考文献17

  • 1急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1321
  • 2Mehra R. Global public health problem of sudden cardiac death[J].{H}Journal of electrocardiology,2007.S118-S122.
  • 3Wessel N,Dash S,Kurths J. Asymmetry of the acceleration and deceleration capacity of heart rate is strongly dependent on ventricular premature complexes[J].{H}Biomed Tech(Berlin),2007,(03):264-266.
  • 4郭继鸿;胡大一.中国心律学2009[M]{H}北京:人民卫生出版社,200997-109.
  • 5Kantelhardt J W,Bauer A,Schumann A Y. Phase-rectified signal averaging for the detection of quasi-periodicities and the prediction of cardiovascular risk[J].{H}CHAOS,2007,(01):15-112.
  • 6Bauer A,Kantelhardt J W,Barthel P. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction:cohort study[J].{H}LANCET,2006,(9523):1674-1681.
  • 7Kupper NH,Willemsen G,Posthuma D. Heritability of ambulatory heart rate variability[J].Circulation,2004,(18):2792.
  • 8郭继鸿;张萍.动态心电图学[M]北京:人民卫生出版社,2003915-934.
  • 9Lombardi F,Tarricone D,Tundo F,et a1. Autonomic nerv-ous system and paroxysmal atrial fibrillation:a study based on the analysis of RR interval changes before,during and after paroxysmal atrial fibrillation[J].European Heart Jour-nal,2004,(14):1242.
  • 10Adamson PB,Smith AL,Abraham WT. Continuous autonomic assessment in patients with symptomatic heart failure;prognostic value of heart rate variability measured by an implanted cardiac resynchronization drvice[J].Circulation,2004,(16):2389.

共引文献14

同被引文献45

  • 1吕滨,郝守艳,汲宏磊,秦孝智,刘延慧,金振一.重组人脑利钠肽对慢性心力衰竭患者心率变异性的影响[J].中国老年学杂志,2014,34(3):608-610. 被引量:6
  • 2杨玲,马全有,刘旭.120例酒依赖者的心电图分析[J].中国药物依赖性杂志,2006,15(2):40-41. 被引量:7
  • 3Smith ML, Hamden MH, Wasmund SL, etal. High -frequency ventricular ectopy can increase sympathetic neural activity in humans [J]. Heart Rhythm, 2010, 7 (4): 497-503.
  • 4Porta A9 Bari V, Badilini F, et aT. Frequency domain assessment of the coupling strength between ventricular repolarization duration and heart period during graded head - up tilt [ J ]. J Electrocardiology, 2011, 44 (6) : 662 -668.
  • 5Nicolini P, Ciulla MM, De Asmundis C, et al. The prognostic value of heart rate variability in the elderly, changing the perspective: from sympathowagal balance to chaos theory [ J ]. Pacing Clin Electrophysiol, 2012, 35 (5): 622-638.
  • 6Xhyheri B, Manfrini O, Mazzolini M, et al. Heart rate variability today [J]. Prog Cardiovase Dis, 2012, 55 (3): 321-331.
  • 7Panagopoulou V, Deftereos S, Kossyvakis C, et al. NTproBNP: an important biomarker in cardiac disease[ J]. Gurr Top Med Chem, 2013,13(2) :82 -94.
  • 8Buri F, McNallan $M, Redfield MM, et al. Pulmonary pressures and death in heart failure.. A community study[ J]. J Am Coll Car- diol,2012,59(3) :222-231.
  • 9Vodovar N, Smnde MF, Laribi S, et al. Elevated Plasma B-type natfiuretic peptide concentrations directly inhibit circulating ne- prilysin activity in heart failure [ J ]. JACC Heart Fail, 2015,3 (8) :629 -635.
  • 10Velde ARVD, Meijers WC, Boer RAD. Biomarkers for risk pre- diction in acute decompensated heart failure [ J ]. Curt Heart Fail Rep,2014,11 ( 3 ) :246 - 259.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部